Literature DB >> 26641540

The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study.

Gineke Koopmans-Klein1,2, Michel F M Wagemans3, Hans C H Wartenberg4, Yvonne J B Van Megen1, Frank J P M Huygen2.   

Abstract

BACKGROUND: Dutch clinical guidelines recommend that a standard laxative treatment (SLT) should be prescribed concomitantly when starting opioid treatment to prevent opioid-induced constipation (OIC).
METHODS: Clinical evidence for SLT in the treatment of OIC is lacking, therefore an observational pilot study was performed to explore the efficacy and tolerability of SLT on OIC in patients treated with the opioid oxycodone.
RESULTS: Twenty-four patients (58% female, median (range) age 65 (39-92)) were included in this pilot study. The analysis showed that 9 out of 21 patients (43%) were non-responders to SLT. When also taking into consideration patients tending to develop diarrhea 75% of patients are non-responsive to SLT.
CONCLUSION: This pilot study indicates that optimal laxative therapy (SLT) might not be effective and feasible for the prevention and treatment of OIC.

Entities:  

Keywords:  Opioid induced constipation; laxatives; observational study; oxycodone; pilot study; real-life data

Mesh:

Substances:

Year:  2015        PMID: 26641540     DOI: 10.1586/17474124.2016.1129275

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  4 in total

1.  Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation.

Authors:  Eike Floettmann; Khanh Bui; Mark Sostek; Kemal Payza; Michael Eldon
Journal:  J Pharmacol Exp Ther       Date:  2017-03-23       Impact factor: 4.030

Review 2.  Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy.

Authors:  Joseph V Pergolizzi; Robert B Raffa; Marco Pappagallo; Charles Fleischer; Joseph Pergolizzi; Gianpietro Zampogna; Elizabeth Duval; Janan Hishmeh; Jo Ann LeQuang; Robert Taylor
Journal:  Patient Prefer Adherence       Date:  2017-01-17       Impact factor: 2.711

3.  Prevalence and Risk Factors for Opioid-Induced Constipation in an Older National Veteran Cohort.

Authors:  Fern FitzHenry; Svetlana K Eden; Jason Denton; Hui Cao; Aize Cao; Ruth Reeves; Guanhua Chen; Glenn Gobbel; Nancy Wells; Michael E Matheny
Journal:  Pain Res Manag       Date:  2020-03-29       Impact factor: 3.037

4.  Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study.

Authors:  Carsten Bantel; Shiva S Tripathi; David Molony; Tony Heffernan; Susmita Oomman; Vivek Mehta; Sara Dickerson
Journal:  Clin Exp Gastroenterol       Date:  2018-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.